Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OM-85 for prevention of severe lower respiratory infections and asthma risk in high-risk infants
ACTRN12612000518864Phase 3Completed
- Sponsor
- Child Health Research Centre
- Start
- Apr 2013
- Modality
- Whole Cell Cancer Vaccines → Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial of OM-85 in asthma, sponsored by Child Health Research Centre. Primary endpoint: Frequency of severe lower respiratory tract infections. Started Apr 2013; status: completed.
02
Drugs
OM-85
03
Conditions
asthma
Beyond the preview
Go deeper on ACTRN12612000518864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000518864.